Recent Updates
Recently added Catalysts
AORT Positive Sentiment Score: 70/100

Artivion Announces Release Date and Teleconference Call Details for First Quarter 2023 Financial Results Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2023...

Key Takeaway: Artivion, Inc. has announced that it will release its financial results for the first quarter of 2023 on May 4, 2023, after market close. The company will host a teleconference and live webcast at 4:30 p.m. ET on the same day, featuring a Q&A session led by Pat Mackin, the CEO. Additionally, the investors can access detailed financial information on Artivion's website after the earnings release.

Market Sentiment Analysis

POSITIVE FACTORS

  • Artivion is set to release its first quarter 2023 financial results, indicating ongoing business activity.
  • The company is actively engaging with shareholders through a scheduled teleconference and webcast.
  • Artivion's focus on developing solutions for aortic disease showcases its commitment to addressing significant medical needs.

Full Press Release Details

ATLANTA , April 20, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT ), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2023 financial results will be released on Thursday, May 4, 2023 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question and answer session hosted by Pat Mackin , Chairman, President and Chief Executive Officer of Artivion.
To listen to the live teleconference, please dial 862-298-0702 a few minutes prior to 4:30 p.m. ET . The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13737780.
The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.
About Artivion, Inc.
Headquartered in suburban Atlanta, Georgia , Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com .
Contacts:
Artivion Gilmartin Group LLC
D. Ashley Lee Brian Johnston / Lynn Lewis
Executive Vice President & Phone: 332-895-3222
Chief Financial Officer [email protected]
Phone: 770-419-3355
SOURCE Artivion, Inc.

21 %

Frequently Asked Questions

When will Artivion release its Q1 2023 financial results?

Artivion will release its Q1 2023 financial results on May 4, 2023.

How can I access the Artivion teleconference?

Dial 862-298-0702 a few minutes before 4:30 p.m. ET to join the teleconference.

Where can I watch the Artivion live webcast?

The live webcast can be accessed in the Investors section on Artivion's website.

What products does Artivion specialize in?

Artivion specializes in aortic stent grafts, surgical sealants, and heart valves.

Which markets does Artivion serve?

Artivion markets its products in over 100 countries worldwide.

Last updated: Apr 20, 2023